Calculate your body mass index (BMI)
Chronic Plaque Psoriasis
Screening and outpatient study dates are flexible.
Up to: $2,290
Male, Female, Smoker, Non-Smoker
The Baltimore Early Phase Unit is currently seeking volunteers with chronic plaque psoriasis to participate in an outpatient clinical research trial evaluating a new investigational drug. The study involves 1 screening visit, 4 doses of the investigational medication (approximately every 2 weeks), and 10 outpatient visits. You may be randomized to receive the study medication or placebo. Qualified participants must have a current diagnosis of chronic plaque psoriasis, involving ≥5% body surface area (not including the face and scalp), for at least six months. Additionally, participants must be able and willing to washout of topical medicated treatments (e.g. Clobex) for 14 days and other systemic or biologic treatments (i.e. prescription medication such as Enbrel, Remicade, etc.) for 28 days-3 months (depending on the medication).
Note: to estimate the body surface area of your psoriasis, use your palm as a unit of measurement. Roughly, 1 palm sized area of psoriasis = 1% body surface area. For this study, participants are required to have ≥5% body surface area or approximately 5 or more palm-sized areas of psoriasis on the body (not including the face and scalp).